BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 25363611)

  • 1. Immunohistochemical expression of interleukin-2 receptor and interleukin-6 in patients with prostate cancer and benign prostatic hyperplasia: association with asymptomatic inflammatory prostatitis NIH category IV.
    Engelhardt PF; Seklehner S; Brustmann H; Lusuardi L; Riedl CR
    Scand J Urol; 2015 Apr; 49(2):120-6. PubMed ID: 25363611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate.
    Dikov D; Bachurska S; Staikov D; Sarafian V
    Prostate; 2015 Jul; 75(10):1074-84. PubMed ID: 25917232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can expressed prostatic secretions effect prostate biopsy decision of urologist?
    Ergun O; Capar E; Goger YE; Ergun AG
    Int Braz J Urol; 2019; 45(2):246-252. PubMed ID: 30648827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-α expression in patients with obstructive benign prostatic hyperplasia is associated with a higher incidence of asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification.
    Engelhardt PF; Seklehner S; Brustmann H; Riedl C; Lusuardi L
    Scand J Urol; 2015 Dec; 49(6):472-478. PubMed ID: 25959105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification in patients with obstructive benign prostatic hyperplasia.
    Engelhardt PF; Seklehner S; Brustmann H; Riedl CR; Lusuardi L
    Minerva Urol Nefrol; 2016 Jun; 68(3):242-9. PubMed ID: 26013949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
    Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
    Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic asymptomatic inflammation of the prostate type IV and carcinoma of the prostate: is there a correlation?
    Engelhardt PF; Brustmann H; Seklehner S; Riedl CR
    Scand J Urol; 2013 Jun; 47(3):230-5. PubMed ID: 23082817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative stress--cause or consequence of male genital tract disorders?
    Kullisaar T; Türk S; Punab M; Mändar R
    Prostate; 2012 Jun; 72(9):977-83. PubMed ID: 22025397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression.
    Al-Maghrebi M; Kehinde EO; Al-Mulla F; Anim JT
    Ann Saudi Med; 2012; 32(3):262-8. PubMed ID: 22588437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
    Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
    Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of estrogen receptor beta in benign prostatic hyperplasia complicated by chronic prostatitis].
    Yang GQ; Li SW; Zheng H; Zhang WB; Hu WL; Zheng XM
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):314-7. PubMed ID: 19472903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress parameters in patients with prostate cancer, benign prostatic hyperplasia and asymptomatic inflammatory prostatitis: A prospective controlled study.
    Kaya E; Ozgok Y; Zor M; Eken A; Bedir S; Erdem O; Ebiloglu T; Ergin G
    Adv Clin Exp Med; 2017 Oct; 26(7):1095-1099. PubMed ID: 29211357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation of IPSS with IL-8 and COX-2 levels in patients with benign prostatic hyperplasia and prostatitis].
    Chen DA; Yang XZ; Zhang PH; Li GS; Chang DG
    Zhonghua Nan Ke Xue; 2013 Jun; 19(6):527-30. PubMed ID: 23862231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
    Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
    J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of proinflammatory cytokine interleukin-6 in tissue samples of human prostate obtained by needle biopsy.
    Miličević N; Mrčela M; Galić J; Marjanović K
    Pathol Res Pract; 2015 Nov; 211(11):865-70. PubMed ID: 26376467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy.
    De Luca S; Passera R; Bollito E; Manfredi M; Scarpa RM; Sottile A; Randone DF; Porpiglia F
    Anticancer Res; 2014 Dec; 34(12):7159-65. PubMed ID: 25503144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
    Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
    Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there any association between National Institute of Health category IV prostatitis and prostate-specific antigen levels in patients with low-risk localized prostate cancer?
    Doluoglu OG; Ceylan C; Kilinc F; Gazel E; Resorlu B; Odabas O
    Int Braz J Urol; 2016; 42(2):346-50. PubMed ID: 27256190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen.
    Carver BS; Bozeman CB; Williams BJ; Venable DD
    J Urol; 2003 Feb; 169(2):589-91. PubMed ID: 12544313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.